An anti-obesity drug made from a Kalahari desert cactus is a step closer to reality after its developer, UK drug company Phytopharm, signed a fresh deal with US giant Pfizer...In the hope of staving off the anger that sometimes surrounds companies which exploit traditional medicines without rewarding their original discoverers, the company signed a deal in 1997 with the South African government for a cut of the royalties.